Dr Reddy's Srikakulam facility gets US FDA Form 483

• Dr Reddy's received a US FDA Form 483 for its Srikakulam, Andhra Pradesh formulations facility.
• The FDA inspection, a combination of GMP review and PAI, occurred from December 4-12, 2025.
• Five observations were issued by the US FDA during the inspection.
• Dr Reddy's stated it will address the FDA observations within the stipulated timeline.
• The company's shares ended 0.5% higher on Friday, despite a 6% year-to-date fall.

Why It Matters: FDA Form 483 signals potential compliance issues for Dr Reddy's.